34.34M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry

Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development that leads to the commercialization of approximately twenty products across four main market segments.

Similar securities

Based on sector and market capitalization

Report issue